The Alzheimer’s Drug Discovery Foundation (ADDF) has experienced significant revenue growth over the past several years. As a result, the Foundation has created a new full-time role of Senior Director for Drug Development. This person will be a mid-career neuroscientist seeking to accelerate the development of late stage preclinical and clinical stage drug development for Alzheimer’s disease and related dementias. As part of a venture philanthropy that funds academic and biotechnology programs, this role will provide leadership, oversight and management to ADDF’s drug development research portfolio and related strategic partnerships. The Senior Director for Drug Development will manage a team of neuroscientists and report directly to the Founding Executive Director and Chief Science Officer.
Work with the Chief Science Officer to provide strategic direction, program planning, progress oversight and attainment of shared goals and milestones of the ADDF late stage preclinical drug discovery and clinical stage drug development (“Core”) program.
Lead a team of ADDF neuroscientists dedicated to ADDF’s Core program.
Provide thought leadership and management of the Foundation’s portfolio of Core programs for Alzheimer’s disease and related dementias.
Proactively search and identify promising academic and biotech investment opportunities, such as meeting with academic and biotechnology investigators, attending scientific conferences, mining scientific and patent literature, and connecting with key opinion leaders.
Provide guidance on due diligence and evaluation of academic and biotechnology Core proposals
Facilitate collaboration within the ADDF teams as well as ADDFs external partnership programs with other foundations, government and industry.
Facilitate the formation of interdisciplinary drug development teams through a network of ADDF consultants, collaborators, and partnerships.
As required, participate in the development and publication of peer-reviewed scientific publications, conference meeting reports, and other related Core program materials for the Foundation.
This position requires a PhD in a relevant biomedical discipline. The ideal candidate will have:
A minimum of 10 years of drug discovery and clinical drug development experience in neuroscience or neurology from the pharmaceutical industry or a combination of industry and academia/nonprofit. Specific experience in the field of Alzheimer’s disease is strongly preferred.
Experience in conceptualizing, designing, conducting, analyzing and reporting clinical trials is required. A focus and receptiveness to scientific risk and innovative thinking will be an important asset.
Proven experience leading and motivating diverse teams of scientists and clinical trialists, and delivering high quality data for preclinical and clinical studies.
Strong interpersonal skills and the ability to work closely and collaboratively with partner organizations, key opinion leaders, donors, and across all ADDF departments.
Excellent oral communications and writing skills with demonstrated ability to communicate to both scientific and lay audiences.
Exceptional project and time management skills with the ability to manage competingrequests and shifting deadlines.
The position is located in midtown Manhattan, New York and will require on-site availability post Covid-19. Compensation will be commensurate with experience. A generous benefits package is included with compensation.
Please send a cover letter and resume including salary requirements to firstname.lastname@example.org and include “Senior Director for Drug Development” in the subject of the email.
Only resumes with accompanying cover letters will be considered. No phone calls, please.
ADDF does not discriminate on the basis of race, color, national origin, sex, religion, age, disability, sexual orientation, gender identity, veteran status, height, weight, or marital status in employment or the provision of services and is an equal access/equal opportunity employer.
Internal Number: 052020
About Alzheimer's Drug Discovery Foundation
The Alzheimer's Drug Discovery Foundation (ADDF) is a nonprofit organization founded in 1998 by co-chairmen Leonard A. Lauder and Ronald S. Lauder of the Estée Lauder Companies and led by neuroscientist, Dr. Howard Fillit. The ADDF provides funding to scientists who are conducting innovative and promising Alzheimer's disease research worldwide. By supporting research projects around the world, it seeks to increase the chances of finding treatments for Alzheimer's disease, related dementias, and cognitive aging.